ArticleExperimental hematology2010

Interferon-alpha targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway.

Min Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.